Product Information
DESOXIMETASONE 0.25% SPRAY is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.6480 per ML under NDC 45802080798. Its NADAC has been published 281 times since May 22, 2019.
FDA first approved this application on Jan 20, 2017. Its Orange Book therapeutic-equivalence code is AT.
Strength
2.5 mg/mL
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802080798
Classification
Generic
Dosage Form
SPRAY
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
DESOXIMETASONEApproval Type
Generic (ANDA)
FDA Application
ANDA206441FDA Approved
1/20/2017
TE Code
AT
On Market Since
12/6/2018
Pharmacological Classes
Price Statistics
The NADAC for DESOXIMETASONE 0.25% SPRAY has been published 281 times since May 22, 2019, and over the history we have for it it has declined 47.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6480 per ML |
|---|---|
| All-time high | $1.4433 (Jun 14, 2023) |
| All-time low | $0.5511 (Mar 18, 2026) |
| 52-week high | $0.7642 |
| 52-week low | $0.5511 |
| Median price | $1.2295 |
| Average price | $1.0675 |
| Largest weekly change | -32.6% (Apr 17, 2024) |
| Weeks tracked | 281 |
| Tracking since | May 22, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the desoximetasone market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
desoximetasone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DESOXIMETASONE 0.25% SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for DESOXIMETASONE 0.25% SPRAY, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.6480 per ML (NDC 45802080798), effective Sep 30, 2026.
How has the price of DESOXIMETASONE 0.25% SPRAY changed over time?
Over the history we have for it, the NADAC for DESOXIMETASONE 0.25% SPRAY has declined 47.3%. It has been tracked across 281 weekly CMS publications since May 22, 2019.
What are the highest and lowest recorded NADAC prices for DESOXIMETASONE 0.25% SPRAY?
Since May 22, 2019, the NADAC for DESOXIMETASONE 0.25% SPRAY has ranged from a low of $0.5511 (Mar 18, 2026) to a high of $1.4433 (Jun 14, 2023), with a median of $1.2295 per ML.
Are there cheaper alternatives to DESOXIMETASONE 0.25% SPRAY?
No other NADAC-published product currently shares the active ingredient and strength of DESOXIMETASONE 0.25% SPRAY in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DESOXIMETASONE 0.25% SPRAY?
DESOXIMETASONE 0.25% SPRAY (NDC 45802080798) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.